China Non Invasive Prenatal Testing Market Size & Outlook
China non invasive prenatal testing market, 2018-2030 (US$M)
Related Markets
China non invasive prenatal testing market highlights
- The China non invasive prenatal testing market generated a revenue of USD 176.4 million in 2022 and is expected to reach USD 397.9 million by 2030.
- The China market is expected to grow at a CAGR of 10.7% from 2023 to 2030.
- In terms of segment, 13-24 weeks was the largest revenue generating gestation period in 2022.
- 0-12 weeks is the most lucrative gestation period segment registering the fastest growth during the forecast period.
Non invasive prenatal testing market data book summary
| Market revenue in 2022 | USD 176.4 million |
| Market revenue in 2030 | USD 397.9 million |
| Growth rate | 10.7% (CAGR from 2022 to 2030) |
| Largest segment | 13-24 weeks |
| Fastest growing segment | 0-12 weeks |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | 0-12 weeks, 13-24 weeks, 25-36 weeks |
| Key market players worldwide | CooperSurgical, Natera Inc, Eurofins Scientific SE, Illumina Inc, Centogene NV Ordinary Shares, MedGenome, Myriad Genetics Inc, Roche Holding AG, Qiagen NV, Labcorp Holdings Inc, Quest Diagnostics Inc, Biora Therapeutics |
Other key industry trends
- In terms of revenue, China accounted for 4.6% of the global non invasive prenatal testing market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China non invasive prenatal testing market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 242.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Non Invasive Prenatal Testing Market Scope
Non Invasive Prenatal Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China non invasive prenatal testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non invasive prenatal testing market will help companies and investors design strategic landscapes.
13-24 weeks was the largest segment with a revenue share of 51.81% in 2022. Horizon Databook has segmented the China non invasive prenatal testing market based on 0-12 weeks, 13-24 weeks, 25-36 weeks covering the revenue growth of each sub-segment from 2018 to 2030.
The China NMPA FDA (CFDA) is responsible for the IVD registration process. Most IVD products in China are regulated in the device group, with only a few defined as drugs. Mostly, they follow similar guidelines for review and registration as medical devices.
The Class I IVDs do not need registration; all required is filing for a notification application. In China, mostly all Class II and III IVDs are required to go through local clinical studies. The Class III IVDs must undergo a multicenter clinical survey with at least three sites.
In 2017, China's State Council issued new guidelines allowing some foreign clinical trial data for IVD registration. Clinical studies must be conducted at multiple locations and meet CFDA registration requirements. This new guideline can reduce the time needed for registration and lower the barriers to entry for foreign manufacturers.
Reasons to subscribe to China non invasive prenatal testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China non invasive prenatal testing market databook
-
Our clientele includes a mix of non invasive prenatal testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China non invasive prenatal testing market , including forecasts for subscribers. This country databook contains high-level insights into China non invasive prenatal testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China non invasive prenatal testing market size, by gestation period, 2018-2030 (US$M)
China Non Invasive Prenatal Testing Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
